This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Biosion, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2025.
Company Filing History:
1 out of 11 
1 out of 121 Years Active: 2025
Title: Innovations of Xiaofang Zou in Rheumatoid Arthritis Treatment
Introduction
Xiaofang Zou is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of rheumatoid arthritis. His innovative work has led to the development of a unique quinoline derivative that shows promise in alleviating the symptoms of this chronic condition.
Latest Patents
Xiaofang Zou holds a patent for a quinoline derivative specifically designed for treating rheumatoid arthritis. The patent details a compound known as 1-[[[4-(4-Fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropanamine. This compound is utilized in preparing a pharmaceutical composition aimed at effectively treating rheumatoid arthritis.
Career Highlights
Zou is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but also holds potential for improving the quality of life for patients suffering from rheumatoid arthritis.
Collaborations
Xiaofang Zou collaborates with several talented individuals in his field, including Xiquan Zhang and Ling Yang. Their combined expertise fosters an environment of innovation and progress in pharmaceutical research.
Conclusion
Xiaofang Zou's contributions to the treatment of rheumatoid arthritis through his innovative quinoline derivative exemplify the impact of dedicated research in the pharmaceutical industry. His work continues to inspire advancements in medical treatments and offers hope to those affected by this condition.